Endometrial cancer: open trials in Finland

11 open trials have a site in Finland. Registry data; only the trial team decides who can take part.

NCT07166094
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
Trial Treatment · Phase 3 · Genmab
Hus Ccc/Ctu, Helsinki · Kuopio Univ. Hospital, PSHVA, Kuopio · Oulu University Hospital, Oulu · Tampere University Hospital, Tampere
Registry updated 2026-11-03
NCT07262619
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
Trial Treatment · Phase 1/2 · Eikon Therapeutics
Kuopio University Hospital, Kuopio
Registry updated 2026-10-30
NCT06340568
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
Trial Treatment · Phase 3 · BioNTech SE
Pohjois-Savon hyvinvointialue, Kuopio · Oulu University Hospital, Oulu · Tampere University Hospital, Tampere · Turku University Hospital, Turku
Registry updated 2026-10-16
NCT06952504
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
HUS-Yhtymae, Helsinki · Kuopio University Hospital, Kuopio · Tampere University Hospital, Tampere · Turku University Hospital, Turku
Registry updated 2026-10-13
NCT06989112
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Trial Treatment · Phase 3 · AstraZeneca
HUS-Yhtymae, Helsinki · Oulu University Hospital, Oulu · Tampere University Hospital, Tampere · Turku University Hospital, Turku
Registry updated 2026-10-13
2025-524160-38-00
A clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
HUS-Yhtymae, Helsinki · Tampere University Hospital, Tampere
Registry updated 2026-10-01
2024-519818-31-01
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator’s Choice in Participants With Endometrial Cancer ( RAINFOL-03 )
Trial Treatment · Phase 3 · Genmab A/S
HUS-Yhtymae, Helsinki · Pohjois-Savon hyvinvointialue, Kuopio · Pohjois-Pohjanmaan hyvinvointialue, Oulu · Pirkanmaan hyvinvointialue, Tampere
Registry updated 2026-08-10
NCT07044336
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Trial Treatment · Phase 3 · AstraZeneca
Kuopio University Hospital, Kuopio · Tampere University Hospital, Tampere · Turku University Hospital, Turku
Registry updated 2026-07-29
NCT07594327
Quality of Life and Sexuality After Pelvic Exenteration for Gynecologic Cancer
Research · Tampere University Hospital
Tampere University Hospital, Tampere
Registry updated 2026-05-22
NCT05655260
PErsonalized TReatment for Endometrial Carcinoma
Trial Treatment · University of Helsinki
Helsinki University Hospital, Helsinki
Registry updated 2024-12-06
NCT05797831
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Trial Treatment · Phase 2/3 · Kartos Therapeutics, Inc.
Kuopio University Hospital, Kuopio · Turku University Hospital, Turku
Registry updated 2024-05-02

All Endometrial cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error